05/14/2025
11:29 AM | Edgewise Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
6:13 PM | Edgewise Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SCHEDULE 13D/A | |
05/08/2025
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:05 AM | Edgewise Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2025
8:09 PM | Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2025
8:09 PM | Donovan Joanne M. (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2025
8:10 PM | Edgewise Therapeutics (Issuer)
KOCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2025
8:10 PM | Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2025
8:10 PM | Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2025
8:08 PM | Carruthers R Michael (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2025
3:15 PM | Edgewise Therapeutics (Filer)
| Form DEF 14A | |
Get the Latest News and Ratings for EWTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Edgewise Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/29/2025
3:16 PM | Edgewise Therapeutics (Filer)
| Form DEFA14A | |
04/04/2025
6:33 PM | Edgewise Therapeutics (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
6:42 PM | Edgewise Therapeutics (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
5:11 PM | Edgewise Therapeutics (Issuer)
Fox Jonathan C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
5:29 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2025
5:06 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2025
3:32 PM | Edgewise Therapeutics (Issuer)
KOCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:33 PM | Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2025
7:05 AM | Edgewise Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2025
4:57 PM | Edgewise Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SCHEDULE 13G | |
02/14/2025
10:24 AM | Edgewise Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G | |
02/07/2025
3:37 PM | Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:38 PM | Edgewise Therapeutics (Issuer)
KOCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:38 PM | Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:19 PM | Edgewise Therapeutics (Subject)
Russell Alan J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
3:20 PM | Edgewise Therapeutics (Subject)
KOCH KEVIN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
3:36 PM | Edgewise Therapeutics (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SCHEDULE 13G | |
01/28/2025
3:18 PM | Donovan Joanne M. (Reporting)
Edgewise Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025
6:56 PM | Blaustein Robert (Reporting)
Edgewise Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/23/2025
6:56 PM | Blaustein Robert (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
7:20 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
4:13 PM | Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:10 PM | Edgewise Therapeutics (Subject)
Russell Alan J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2024
3:30 PM | Edgewise Therapeutics (Issuer)
Semigran Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:15 AM | Edgewise Therapeutics (Subject)
Semigran Marc (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
4:25 PM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:22 PM | EcoR1 Capital, LLC (Filed by)
Edgewise Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
7:59 AM | Edgewise Therapeutics (Subject)
Flynn James E (Filed by)
| Form SC 13G/A | |
11/12/2024
8:55 AM | Edgewise Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
11/07/2024
7:53 AM | Edgewise Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/07/2024
7:07 AM | Edgewise Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
Edgewise Therapeutics (Subject)
| Form SC 13G | |
10/16/2024
3:23 PM | Carruthers R Michael (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:22 PM | Carruthers R Michael (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:24 PM | Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:24 PM | Donovan Joanne M. (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:25 PM | Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
7:25 PM | Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
8:20 PM | Edgewise Therapeutics (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13D/A | |
09/20/2024
4:37 PM | Donovan Joanne M. (Reporting)
Edgewise Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
3:46 PM | Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
3:29 PM | Edgewise Therapeutics (Subject)
Russell Alan J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
4:07 PM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
7:06 AM | Edgewise Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/10/2024
9:10 AM | Edgewise Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
06/12/2024
6:23 PM | Edgewise Therapeutics (Issuer)
Edris Badreddin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
6:25 PM | Brege Laura (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
6:26 PM | Edgewise Therapeutics (Issuer)
Morris Arlene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
6:32 PM | Edgewise Therapeutics (Issuer)
Fox Jonathan C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
6:33 PM | Edgewise Therapeutics (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
6:22 PM | Edgewise Therapeutics (Issuer)
ROOT JONATHAN D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
8:09 PM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
